Additional file 2: of Characteristics of insulin-Naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: a meta-analysis of individual participant data from 3 randomized clinical trials

Cummings, M.; Cao, D.; Hadjiyianni, I.; Ilag, L.; Tan, M.

doi:10.6084/m9.figshare.6234518.v1

40842_2018_59_MOESM2_ESM.docx (35.02 kB)

Additional file 2: of Characteristics of insulin-Naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: a meta-analysis of individual participant data from 3 randomized clinical trials

journal contribution

posted on 2018-05-08, 05:00 authored by M. Cummings, D. Cao, I. Hadjiyianni, L. Ilag, M. Tan

Table S2. Outcomes of responders and nonresponders to IGlar at 24 weeks by study. Data are HbA1c, insulin dose, and FBG change from baseline to 24 weeks categorized by response (i.e., responders and nonresponders) in each study. (DOCX 35 kb)

Funding

Eli Lilly and Company

History

Usage metrics

Keywords

Type 2 diabetes Insulin glargine Insulin naïve Responders HbA1c composite endpoint Baseline characteristics

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC